On August 1, 2025, the JPML reported there are 2,190 cases pending in MDL -3094 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
1st St., Suite 202 Fort Worth, TX 76102 817.993.9249 KELLER 101 Quest Court Keller, TX 76248 817.482.6770
Promotes Fat Storage: GIP also signals your body to store fat, which can contribute to weight gain if theres too much GIP in your system
Complete appetite loss often causes under-eating, weakness, and unpleasant side effects
To support muscle, overall health, and prevent potential deficiencies while using GLP-1 medications, I recommend: Anchor meals and snacks with protein
For everyone, a strict site rotation strategy isn't optional